Montara Therapeutics
PrivateLast Round
Grant
Jun 2, 2026
Total Funding Raised
$32.3M
Company Overview
Montara Therapeutics is a biotechnology company that develops brain-selective therapies for central nervous system diseases using its proprietary BrainOnly™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Montara Therapeutics Comparables
Compare Montara Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Violet Therapeutics | 72% | |
| AbbVie | 71% | |
| Acurex Biosciences | 68% |
Montara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Grant | May 21, 2025 | ||||
| Seed | Mar 13, 2025 | ||||
| Seed | Jul 30, 2024 | ||||
| Seed | Jan 19, 2024 |
Key People
Founding team and executive leadership
Montara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| Dolby Family Ventures | Seed |
| SV Health Investors | Seed |
| Two Bear Capital | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Partnering with the TSC Alliance to advance lead program.
- Dec 8, 2025
Initial data on MT1110-everolimus combination presented at AES Annual Meeting.
Montara Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Montara Therapeutics's valuation, stock price, and market status.
Is Montara Therapeutics a public or private company?
Montara Therapeutics is a private company.
What is the current stock price of Montara Therapeutics?
Montara Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Montara Therapeutics worth (valuation)?
Valuation information for Montara Therapeutics is not publicly available.
Can I buy Montara Therapeutics stock?
Montara Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Montara Therapeutics's last funding round?
Montara Therapeutics's most recent funding round was Grant on May 21, 2025.
Who are the main investors in Montara Therapeutics?
Key investors in Montara Therapeutics include SV Health Investors, Two Bear Capital.
Will Montara Therapeutics IPO soon?
No public IPO plans have been announced for Montara Therapeutics.
How can I track Montara Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Montara Therapeutics's secondary market activity and sign up for updates.